外科合伙人
SGRY
14.61
-0.16
-1.08%
外科合伙人
US · SGRY
#2884 按市值排名
上市于 2015
14.61
-0.16
-1.08%
实时 - 追踪5344个代码 - 心跳于533秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
涨跌不一/平稳
- 最近一期(2026/Q3)披露持股的机构数量增加了1家。
- 机构持股总比例基本持平。
机构持股
- 机构持股比例
- 121.85% -0.03pp
- 机构数量
- 222 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund54.30%
VC/PE Fund39.17%
Hedge Fund23.12%
Public Company4.75%
Individual/Insider1.82%
Private Company0.27%
Government Pension Fund0.17%
主要股东 截至 2026-06-30
Bain Capital, LP
38.51% · 49.95M 股
Janus Henderson Group plc
10.70% · 13.88M 股
Pentwater Capital Management LP
8.97% · 11.63M 股
UBS Asset Management
7.74% · 10.04M 股
BlackRock
4.81% · 6.24M 股
King Street Capital Management, L.P.
4.67% · 6.06M 股
T. Rowe Price Group, Inc.
4.66% · 6.04M 股
Dimensional Fund Advisors
3.81% · 4.94M 股
Vanguard Capital Management, LLC
3.10% · 4.02M 股
ClearBridge Investments, LLC
2.95% · 3.82M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 24次买入 · 23次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Bain Capital, LP | -- | 38.51% |
| J. Evans | Chief Executive Officer | 0.71% |
| Jennifer Baldock | Executive VP and Chief Administrative & Development Officer | 0.25% |
| David Doherty | Chief Financial Officer | 0.17% |
| W. Webb | Senior Vice President of Central Region | 0.10% |
| Justin Oppenheimer | COO & National Group President | 0.09% |
| Harrison Bane | President of American Group | 0.09% |
| Marissa Brittenham | Chief Strategy Officer | 0.07% |
| William Turner | Independent Director | 0.07% |
| Danielle Burkhalter | Chief Human Resources Officer | 0.06% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-08-17 | Teresa DeLuca | Independent Director | Open Market Acquisition | +11,250 | $14.33 |
| 2026-06-17 | Blair Hendrix | Director | Other Acquisition | +34,364 | $14.55 |
| 2026-06-04 | Clifford Adlerz | Director | Other Acquisition | +11,670 | $13.71 |
| 2026-06-04 | Lloyd Dean | Independent Director | Other Acquisition | +11,670 | $13.71 |
| 2026-06-04 | William Turner | Independent Director | Other Acquisition | +11,670 | $13.71 |
| 2026-06-04 | Teresa DeLuca | Independent Director | Other Acquisition | +11,670 | $13.71 |
| 2026-06-04 | John Deane | Independent Director | Other Acquisition | +11,670 | $13.71 |
| 2026-06-04 | Laura Forese | Independent Director | Other Acquisition | +11,670 | $13.71 |
| 2026-03-15 | David Doherty | Chief Financial Officer | Open Market Disposition | -8,867 | $12.50 |
| 2026-03-15 | J. Evans | Chief Executive Officer | Open Market Disposition | -20,400 | $12.47 |
| 2026-03-12 | Marissa Brittenham | Chief Strategy Officer | Open Market Disposition | -3,657 | $12.54 |
| 2026-03-12 | Danielle Burkhalter | Chief Human Resources Officer | Open Market Disposition | -3,469 | $12.83 |
| 2026-03-11 | Jennifer Baldock | Executive VP and Chief Administrative & Development Officer | Open Market Disposition | -5,798 | $13.17 |
| 2026-03-05 | David Doherty | Chief Financial Officer | Other Acquisition | +141,743 | $14.11 |
| 2026-03-05 | J. Evans | Chief Executive Officer | Other Acquisition | +278,106 | $14.11 |
| 2026-03-05 | Jennifer Baldock | Executive VP and Chief Administrative & Development Officer | Open Market Disposition | -10,082 | $13.70 |
| 2026-03-05 | Marissa Brittenham | Chief Strategy Officer | Other Acquisition | +43,230 | $14.11 |
| 2026-03-05 | Danielle Burkhalter | Chief Human Resources Officer | Private Disposition | -7,736 | $13.60 |
| 2026-03-05 | W. Webb | Senior Vice President of Central Region | Other Acquisition | +31,892 | $14.11 |
| 2026-03-04 | David Doherty | Chief Financial Officer | Open Market Disposition | -14,574 | $13.84 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
外科合伙人 讨论区 0 条评论